Associated Papers
Thrombotic Microangiopathy After Kidney Transplantation: Insights Into Genetic Etiology and Clinical Outcomes.
Merzkani M et al.
Kidney International Reports, 2025
Inborn errors of immunity with kidney and urinary tract disorders: a review.
Shajari A et al.
International Urology and Nephrology, 2024
On the relevance of thrombomodulin variants in atypical hemolytic uremic syndrome.
Huerta A et al.
Kidney International, 2023
Thrombomodulin (THBD) gene variants and thrombotic risk in a population-based cohort study.
Manderstedt E et al.
Journal of Thrombosis and Haemostasis : Jth, 2022
Whole genome deep sequencing analysis of cell-free DNA in samples with low tumour content.
Ganesamoorthy D et al.
Bmc Cancer, 2022
Thrombomodulin gene polymorphism and the occurrence and prognostic value of sepsis acute kidney injury.
Li Q et al.
Medicine, 2021
Complement Gene Variants and Shiga Toxin-Producing Escherichia coli-Associated Hemolytic Uremic Syndrome: Retrospective Genetic and Clinical Study.
Frémeaux-Bacchi V et al.
Clinical Journal of the American Society of Nephrology : Cjasn, 2019
Routine use of clinical exome-based next-generation sequencing for evaluation of patients with thrombotic microangiopathies.
Gaut JP et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc, 2017
Massively parallel sequencing and targeted exomes in familial kidney disease can diagnose underlying genetic disorders.
Mallett AJ et al.
Kidney International, 2017
Post-transplant recurrence of atypical hemolytic uremic syndrome in a patient with thrombomodulin mutation.
Sinibaldi S et al.
Pediatric Transplantation, 2013
Thrombomodulin mutations in atypical hemolytic-uremic syndrome.
Delvaeye M et al.
The New England Journal of Medicine, 2009
Genome-wide analysis to predict protein sequence variations that change phosphorylation sites or their corresponding kinases.
Ryu GM et al.
Nucleic Acids Research, 2009
Naturally occurring mutations in the thrombomodulin gene leading to impaired expression and function.
Kunz G et al.
Blood, 2002
Thrombomodulin promoter mutations, venous thrombosis, and varicose veins.
Le Flem L et al.
Arteriosclerosis, Thrombosis, and Vascular Biology, 2001
A novel mutation in complement 2 accompanied by susceptibility variants in C3 glomerulonephritis: A case study.
Han SS et al.
Nefrologia, 0